Skip to main content

Advertisement

Log in

Gastrointestinal mucositis: a new biological model

  • Review Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

The history of research into gastrointestinal mucositis (GIM), and how the future directions are informed by the progress made in the study of oral mucositis (OM) are discussed. It is proposed that OM and GIM should both be considered to be elements of alimentary mucositis (AM), which covers mucosal damage through the entire alimentary tract, with regional differences being due to the specialized needs of each area.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gibson RJ, Keefe DM, Clarke JM, Regester GO, Thompson FM, Goland GJ, Edwards BG, Cummins AG (2002) The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer. Cancer Chemother Pharmacol 50:53–58

    Article  CAS  PubMed  Google Scholar 

  2. Gibson RJ, Keefe DM, Thompson FM, Clarke JM, Goland GJ, Cummins AG (2002) Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats. Dig Dis Sci 47:2751–2757

    Article  CAS  PubMed  Google Scholar 

  3. Gibson RJ, Bowen JM, Inglis MR, Cummins AG, Keefe DM (2003) Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J Gastroenterol Hepatol 18:1095–1100

    Article  PubMed  Google Scholar 

  4. Ikuno N, Soda H, Watanabe M, Oka M (1995) Irinotecan (CPT-11) and characteristic changes in the mouse ileum and cecum. J Natl Cancer Inst 87:1876–1883

    CAS  PubMed  Google Scholar 

  5. Keefe DMK (1998) The effect of cytotoxic chemotherapy on the mucosa of the small intestine. Department of Medicine, University of Adelaide, Adelaide

  6. Keefe DM, Cummins AG, Dale BM, Kotasek D, Robb TA, Sage RE (1997) Effect of high-dose chemotherapy on intestinal permeability in humans. Clin Sci 92:385–389

    PubMed  Google Scholar 

  7. Keefe DM, Brealey J, Goland GJ, Cummins AG (2000) Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 47:632–637

    Article  CAS  PubMed  Google Scholar 

  8. Sonis ST (1998) Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 34:39–43

    CAS  PubMed  Google Scholar 

  9. Trier JS (1962) Morphological alterations induced by methotrexate in the mucosa of human proximal intestine I. Serial observations by light microscopy. Gastroenterology 42:295–305

    CAS  PubMed  Google Scholar 

  10. Trier JS (1962) Morphologic alterations induced by methotrexate in the mucosa of human proximal intestine II. Electron microscopic observations. Gastroenterology 43:407–424

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dorothy M. K. Keefe.

Additional information

This work was presented as an invited lecture at the 15th International Symposium Supportive Care in Cancer, Berlin, Germany, 18–21 June 2003.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keefe, D.M.K. Gastrointestinal mucositis: a new biological model. Support Care Cancer 12, 6–9 (2004). https://doi.org/10.1007/s00520-003-0550-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-003-0550-9

Keywords

Navigation